oral dissolving semaglutide | Starts at $249/mo Oral semaglutide drops - No

ChAdOx/MVA viral vectors / CancerProstate cancerPhase 1Pursuing partnership opportunities for advancementWorldwide rights 3assets LOQTORZI (toripalimab-tpzi)LOQTORZI / PD-1 / Anti-PD-1 monoclonal antibody / Oncology1L Nasopharyngeal Carcinoma (combo with chemotherapy)ApprovedApprovedUnited States2L+ Nasopharyngeal Carcinoma (monotherapy)ApprovedApprovedUnited States TagmokitugCHS-114 / CCR8 / Anti-CCR8 monoclonal antibody / Oncology4L+ Colorectal Cancer (combo with toripalimab)Phase 22L HNSCC (combo with toripalimab)Phase 12L Gastric Cancer/GEJ/EAC (combo with toripalimab)Phase 1 CasdozokitugIL-27 / IL-27 antagonist monoclonal antibody / Oncology1L Hepatocellular Carcinoma (combo with toripalimab + bevacizumab)Phase 2 3assets CTx-1301CTx-1301 / PTR multi-core modified-release dexmethylphenidate tablet / CNSADHDNDA submittedSubmitted July 31, 2025US CTx-1302CTx-1302 / PTR multi-core modified-release dextroamphetamine tablet / CNSADHDPreclinical/formulationInitial formulation study plannedUS CTx-2103CTx-2103 / 5-HT1A partial agonist / PTR multi-core modified-release buspirone tablet / CNSAnxietyPre-INDClinical trials planned 4Q 2026US 3assets Iopofosine I 131CLR 131 / tumor cells via phospholipid drug conjugate delivery / PDC radiotherapeutic

4.57 (46 Reviews) The Ultra White Collagen + L Glutathione Booster is a specialized dietary supplement formulated to support skin health, complexion, and overall anti-aging efforts

GO analysis showed that Sema was involved in mitochondrial activity changes in both groups

Every patient at TrimrX has a consultation with a licensed medical provider who determines if a GLP-1 medication is appropriate for them

Tirzepatide (Mounjaro, Zepbound) Tirzepatide is a dualacting medication that targets both GLP1 and glucosedependent insulinotropic polypeptide (GIP) receptors, which may enhance its effects on appetite regulation and metabolism

Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, and certain kidney or pancreatic conditions